Skip to content
MarketScale
‹ Back to IndustriesHealthcare

From Chaos to Control: Dr. Mo Canellas on AI, Emergency Medicine & Why Most “AI Companies” Fake It

Dr. Maureen 'Mo' Canellas discusses the implementation of AI in emergency medicine and critiques the authenticity of many companies claiming to be AI-focused. She highlights her roles at UMass Memorial Medical Center and collaborations with institutions like MIT. Dr. Canellas also contributes to discussions around health care operations and benchmarking.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from I Don't Care on MarketScale.

By Kevin Stevenson ·
Share

Key takeaways

01

Dr. Mo Canellas is a significant figure in emergency medicine, focusing on machine learning and healthcare operations.

02

Many companies claiming to focus on AI in healthcare do not genuinely implement such technology.

03

Dr. Canellas collaborates with MIT and the Emergency Department Benchmarking Alliance for health care research and advancement.

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Dr. Maureen "Mo" Canellas wears a lot of hats. She is the associate chief medical officer at UMass Memorial Medical Center, a researcher in machine learning and health care operations, a faculty collaborator at MIT, and a longtime contributor to the Emergency Department Benchmarking Alliance. But the thread connecting all of it traces back to a college thesis on the Google search algorithm and a question she has been asking ever since: how do you bring order to chaos? That question is what drew her to emergency medicine, and it is what keeps her at the center of serious conversations about AI in hospital operations.

Canellas sat down with Dr. Kevin Stevenson on the I Don't Care podcast to talk through where health care AI actually stands, what separates real innovation from slide-deck theater, and why the financial structure of hospitals may be the most uncomfortable problem that data science still needs to solve.

Most "AI companies" are really doing data science at best

Canellas did not mince words on the state of vendor claims. The field is crowded with companies that attach the AI label to products that rely on little more than basic analytics. "AI is what you tell your CEO you're doing," she said. "Machine learning is what you tell other people you're doing. And what you're really doing a lot of the times when they're AI enabled, it's data science. It's not, like, a linear algorithm at best." Her test for separating credible vendors from the noise is straightforward: skip the polished pitch and ask granular questions. If someone can think on their feet about data inputs, outputs, and model mechanics, that signals genuine understanding. If they can only navigate the slides they rehearsed, that tells you something too.

For hospital CEOs evaluating AI investments, Canellas recommends bringing a cross-functional team into every vendor conversation rather than letting a single executive be the sole judge. She also points to the Coalition for Health AI, known as CHAI, as a practical resource. The organization is building governance and encryption standards for health care AI by mapping from established frameworks like IEEE and aligning with existing regulatory bodies, including the Joint Commission, which has already published a white paper on responsible AI. Canellas believes Joint Commission surveys will eventually require evidence of CHAI alignment, making early adoption a competitive advantage rather than a compliance burden.

Clinical intuition, patient flow, and the limits of current tools

One of the more provocative ideas Canellas raised is how AI might capture what emergency physicians call clinical gestalt, the experienced gut sense that something is wrong with a patient before the data catches up. Rather than waiting for AI to replicate that instinct autonomously, she proposed a simpler bridge: prompt the physician at the start of an encounter with a single binary question about likely admission. Feed that response into the algorithm. "Why not take that gestalt and see if that improves the outcome?" she asked. "That way the docs are involved, increased adoption, increasing using their brainpower to help the algorithm." It is a practical, incremental approach that reflects her broader philosophy: build AI with clinicians, not around them.

Her work on patient throughput connects directly to a problem she described as one of the most uncomfortable topics in any hospital boardroom: boarding. When patients who need inpatient beds remain parked in the ED, it strains every downstream resource. Canellas has researched the cost differential and presented data-driven financial models to make the case for investment, arguing that simulation AI can project a return on investment before a single dollar is committed. The discomfort, she noted, comes from the fact that the revenue structures governing inpatient and emergency care are fundamentally misaligned, and fixing boarding requires confronting that misalignment directly.

Where health care AI stands and what comes next

Asked to put a baseball inning on health care AI's current progress, Canellas called it the second or third inning. Enough early runs to generate real interest, but far from the decisive middle innings where the best tools separate themselves from the field. She sees the proliferation of AI products across every conceivable use case as analogous to going through a batting order once: now the game starts for real, and teams will begin identifying what actually works. The institutions that will benefit most are those that have already done the foundational governance work, built internal AI literacy, and selected vendors who can answer hard questions without a script.

For health care operators, the practical takeaway from Canellas is consistent across every topic she covers: resist the rose-colored glasses, demand specificity from vendors, invest in standards before regulators require it, and treat AI as a tool that works best when clinicians remain active participants in the loop. The chaos of emergency medicine, she has argued since graduate school, is not a problem to be eliminated. It is a system to be understood well enough to control.

I Don't Care

Part of this channel

I Don't Care

Candid healthcare leadership conversations with Kevin Stevenson

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

Kevin Stevenson
Kevin StevensonTop Hospital Administrator & Healthcare COO, I Don't Care

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

AI is compressing drug discovery timelines from years to months, and clinical operators need to prepare now

AI is compressing drug discovery timelines from years to months, and clinical operators need to prepare now

Generative AI is accelerating drug discovery processes, significantly reducing timelines from years to mere months. Clinical operators must adapt to this rapid change as AI-designed solutions become integral to the healthcare pipeline.

  • 01Generative AI is capable of reducing drug discovery timelines from years to months.
  • 02The integration of AI into healthcare is necessitating changes in clinical operations.
  • 03AI-informed patients are becoming more common in clinical settings.

Aug 12, 2026

Siemens Healthineers and Cleveland Clinic sign a 10-year alliance as ambient AI reshapes the EHR debate

Siemens Healthineers and Cleveland Clinic sign a 10-year alliance as ambient AI reshapes the EHR debate

Siemens Healthineers and Cleveland Clinic have entered into a 10-year alliance focusing on ambient AI and its integration into electronic health records (EHR). This partnership aims to enhance healthcare delivery systems and streamline clinical processes through advanced technology.

  • 01Siemens Healthineers and Cleveland Clinic have formed a 10-year partnership to explore ambient AI in healthcare.
  • 02The alliance focuses on transforming electronic health records (EHR) with the integration of new AI technologies.
  • 03The partnership aims to improve healthcare delivery and streamline clinical processes.

Aug 9, 2026

A Physician Entrepreneur's Journey in Specialty Care Expansion - Dr. Joe Pazona, CEO of VirtuCare

Dr. Joe Pazona shares insights into his journey as a physician entrepreneur focusing on specialty care expansion. He highlights the challenges and strategies involved in growing a healthcare business. The discussion offers valuable lessons for other healthcare professionals looking to innovate and expand in their practices.

  • 01A physician entrepreneur focuses on specialty care expansion.
  • 02Innovative strategies are necessary for growth in healthcare businesses.
  • 03Lessons from healthcare leaders can help others in the industry.

Aug 8, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

Kevin Stevenson
Kevin Stevenson

Associate Chief Medical Officer at UMass Memorial Medical Center

I Don't Care

Dr. Maureen 'Mo' Canellas is the associate chief medical officer at UMass Memorial Medical Center. She is a researcher focused on machine learning and health care operations and a faculty collaborator at MIT. Dr. Canellas is also a contributor to the Emergency Department Benchmarking Alliance.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512